Acxiom Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Acxiom Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4667
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Acxiom Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Acxiom Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Acxiom Corporation (Acxiom or “the company”) is an enterprise data, analytics and software-as-a-service (SaaS) company. The company offers integrated digital marketing solutions, marketing solutions, consumer demographics products, IT infrastructure outsourcing, customer data integration solutions, identity solutions, and professional consulting services. Acxiom it is headquartered in Little Rock, Arkansas, the US.

Scope

- Detailed information on Acxiom Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Acxiom Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Acxiom Corporation including a breakdown and examination of key business segments
- Intelligence on Acxiom Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Acxiom Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Acxiom Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Acxiom Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Acxiom Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Acxiom Corporation: Company Overview 9
Acxiom Corporation: Overview and Key Facts 9
Acxiom Corporation: Overview 9
Acxiom Corporation: Key Facts 9
Acxiom Corporation: Key Employees 10
Acxiom Corporation: Key Employee Biographies 12
Acxiom Corporation: Major Products and Services 19
Acxiom Corporation: Company History 20
Acxiom Corporation: Management Statement 25
Acxiom Corporation: Locations and Subsidiaries 27
Acxiom Corporation: Key Competitors 29
Acxiom Corporation: Company Analysis 30
Acxiom Corporation: Business Description 30
Acxiom Corporation: SWOT Analysis 31
Acxiom Corporation: SWOT Overview 31
Acxiom Corporation: Strengths 31
Acxiom Corporation: Weaknesses 32
Acxiom Corporation: Opportunities 32
Acxiom Corporation: Threats 34
Acxiom Corporation: Corporate Financial Deals Activity 35
Acxiom Corporation: Financial Deals Overview 35
Acxiom Corporation: Targets and Partners 37
Acxiom Corporation: Top Deals 2014 – 2018YTD* 38
Acxiom Corporation: Advisors 39
Acxiom Corporation: Top Legal Advisors 39
Acxiom Corporation: Mergers and Acquisitions 40
Acxiom Corporation: Partnership 41
Acxiom Corporation: Divestments 42
Acxiom Corporation: Private Equity and Ownership 43
Acxiom Corporation: Recent Developments 44
Acxiom Corporation: News and Events Summary 44
Acxiom Corporation: Business Expansion 47
Acxiom Corporation: Contracts 47
Acxiom Corporation: Corporate Governance 48
Acxiom Corporation: Financial Deals 49
Acxiom Corporation: Financial Performance 50
Acxiom Corporation: IT Spending Announcements 50
Appendix 51
Contact Us 51
Methodology 51
About MarketLine 52

List of Tables
Table 1: Acxiom Corporation: Key Facts
Table 2: Acxiom Corporation: Key Employees
Table 3: Acxiom Corporation: Locations and Subsidiaries
Table 4: Acxiom Corporation: Key Competitors
Table 5: Acxiom Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Acxiom Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Acxiom Corporation: M&A Average Deal Size - Value (US$m)
Table 8: Acxiom Corporation: Targets and Partners
Table 9: Acxiom Corporation: Top Deals 2014 - 2018YTD*
Table 10: Acxiom Corporation: Legal Advisor Ranking by Value (US$m)
Table 11: Acxiom Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Acxiom Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Acxiom Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Acxiom Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Acxiom Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: Acxiom Corporation: Divestments by Geography (2014 - YTD*2018)
Table 17: Acxiom Corporation: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 18: Acxiom Corporation: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 19: Acxiom Corporation: News and Events Summary
Table 20: Acxiom Corporation: Business Expansion
Table 21: Acxiom Corporation: Contracts
Table 22: Acxiom Corporation: Corporate Governance
Table 23: Acxiom Corporation: Financial Deals
Table 24: Acxiom Corporation: Financial Performance
Table 25: Acxiom Corporation: IT Spending Announcements

List of Figures
Figure 1: Acxiom Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Acxiom Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Acxiom Corporation: M&A Average Deal Size - Value (US$m)
Figure 4: Acxiom Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Acxiom Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Acxiom Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Acxiom Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 8: Acxiom Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 9: Acxiom Corporation: Divestments by Geography (2014 - YTD*2018)
Figure 10: Acxiom Corporation: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 11: Acxiom Corporation: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Acxiom Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magnis Energy Technologies Ltd (MNS):企業の財務・戦略的SWOT分析
    Magnis Energy Technologies Ltd (MNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Cargolux Airlines International SA:企業の戦略的SWOT分析
    Cargolux Airlines International SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Bonus BioGroup Ltd (BONS):医療機器:M&Aディール及び事業提携情報
    Summary Bonus BioGroup Ltd (Bonus BioGroup), formerly Oceania advanced industries Ltd is a biotechnology company that supplies tissue-engineered viable bone grafts. The company operates in the field of tissue engineering and live bone transplantation. Its products include BonoFill injectable bone gr …
  • Wellcome Trust Sanger Institute-製薬・医療分野:企業M&A・提携分析
    Summary Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research …
  • Park Hotels & Resorts Inc (PK):企業の財務・戦略的SWOT分析
    Park Hotels & Resorts Inc (PK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Fuji Oil Holdings Inc.:戦略・SWOT・企業財務分析
    Fuji Oil Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Oil Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Indra Sistemas SA (IDR):企業の財務・戦略的SWOT分析
    Indra Sistemas SA (IDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Panoramic Resources Ltd:企業の戦略・SWOT・財務情報
    Panoramic Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Panoramic Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Evergreen Fibreboard Berhad:企業の戦略・SWOT・財務情報
    Evergreen Fibreboard Berhad - Strategy, SWOT and Corporate Finance Report Summary Evergreen Fibreboard Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Netherlands Cancer Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • Korea East-West Power Co Ltd:企業の戦略的SWOT分析
    Korea East-West Power Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Abreos Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abreos Biosciences Inc (Abreos) is a biotechnology company with focus on the development of laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator, is a drug-monitoring test that provides physicians with vital information …
  • Medical Properties Trust, Inc.:企業のM&A・事業提携・投資動向
    Medical Properties Trust, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medical Properties Trust, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Rosenergoatom Concern JSC:企業の戦略的SWOT分析
    Rosenergoatom Concern JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Protalex Inc (PRTX):企業の財務・戦略的SWOT分析
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops drugs for the treatment of autoimmune and inflammatory diseases. The company offers treatment for a range of autoimmune diseases such as rheumatoid arthritis and immune thrombocytopenia. Its lead product candidate includes …
  • Kracie Holdings, Ltd.:企業の戦略・SWOT・財務情報
    Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pinar Entegre Et ve Un Sanayi AS:企業の戦略・SWOT・財務情報
    Pinar Entegre Et ve Un Sanayi AS - Strategy, SWOT and Corporate Finance Report Summary Pinar Entegre Et ve Un Sanayi AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Evraz Plc:企業の戦略・SWOT・財務情報
    Evraz Plc - Strategy, SWOT and Corporate Finance Report Summary Evraz Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Kyorin Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kyorin Pharmaceutical Co Ltd (Kyorin), a subsidiary of Kyorin Holdings Inc, is a pharmaceutical company that manufactures and markets prescription medicines. The company offers ethical drugs including mucodyne, kipres, desalex, flutiform, pentasa, ketas and uritos. Its ketas product is a pho …
  • LG Chem Ltd (051910):企業の財務・戦略的SWOT分析
    LG Chem Ltd (051910) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆